Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
TRIP.COM-S
09961
5
MEITUAN-W
03690
No Data
Morgan Stanley Maintains BeiGene(ONC.US) With Buy Rating, Raises Target Price to $390
RBC Capital Adjusts Price Target on BeOne Medicines to $395 From $374, Maintains Outperform Rating
BeOne Medicines Price Target Raised to $396.00/Share From $348.00 by Citizens
BeOne Medicines Is Maintained at Market Outperform by Citizens
Citizens Maintains Market Outperform on BeOne Medicines, Raises Price Target to $396
BeOne Medicines Analyst Ratings